Effect of a preceding laser dermabrasion on the outcome of combined therapy with narrowband ultraviolet B and potent topical steroids for treating nonsegmental vitiligo in resistant localizations

British Journal of Dermatology

Volumn 166, Issue 1, 2012, Pages 208-211

  Bayoumi, W ^a   Fontas, E ^a   Sillard, L ^a   Le Duff, F ^a   Ortonne, J P ^a   Bahadoran, P ^a   Lacour, J P ^a   Passeron, T ^a,b  

^a UNIVERSITY HOSPITAL OF NICE   (France)

^b CENTRE MÉDITERRANÉEN DE MÉDECINE MOLÉCULAIRE C3M   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE BUTYRATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; EDEMA; ERBIUM YAG LASER; FEMALE; HUMAN; HYPERTROPHIC SCAR; INTERMETHOD COMPARISON; LASER DERMABRASION; LASER SURGERY; MALE; PAIN; PATIENT SATISFACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SKIN ABRASION; SKIN PIGMENTATION; SKIN REPIGMENTATION; STEROID THERAPY; THERAPY EFFECT; TOPICAL TREATMENT; TREATMENT OUTCOME; ULTRAVIOLET B RADIATION; VITILIGO; WOUND HEALING IMPAIRMENT;

ADULT; AGED; COMBINED MODALITY THERAPY; DERMABRASION; DERMATOLOGIC AGENTS; FEMALE; HUMANS; HYDROCORTISONE; LASER THERAPY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; ULTRAVIOLET THERAPY; VITILIGO;

EID: 84655169202     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10564.x     Document Type: Article

References (10)

1. Passeron T, Ortonne JP,. Physiopathology and genetics of vitiligo. J Autoimmun 2005; 25 (Suppl.): 63-8. (Pubitemid 41728047)
2. Jin Y, Birlea SA, Fain PR, et al. Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. N Engl J Med 2010; 362: 1686-97.
3. Gregg RK, Nichols L, Chen Y, et al. Mechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice. J Immunol 2010; 184: 1909-17.
4. Gawkrodger DJ, Ormerod AD, Shaw L, et al. Guideline for the diagnosis and management of vitiligo. Br J Dermatol 2008; 159: 1051-76.
5. Whitton ME, Ashcroft DM, Gonzalez U,. Therapeutic interventions for vitiligo. J Am Acad Dermatol 2008; 59: 713-17.
6. Passeron T, Ostovari N, Zakaria W, et al. Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo. Arch Dermatol 2004; 140: 1065-9. (Pubitemid 39223113)
7. Sassi F, Cazzaniga S, Tessari G, et al. Randomized controlled trial comparing the effectiveness of 308-nm excimer laser alone or in combination with topical hydrocortisone 17-butyrate cream in the treatment of vitiligo of the face and neck. Br J Dermatol 2008; 159: 1186-91.
8. Esfandiarpour I, Ekhlasi A, Farajzadeh S, et al. The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial. J Dermatolog Treat 2009; 20: 14-18.
9. Anbar TS, Westerhof W, Abdel-Rahman AT, et al. Effect of one session of ER:YAG laser ablation plus topical 5fluorouracil on the outcome of short-term NB-UVB phototherapy in the treatment of non-segmental vitiligo: a left-right comparative study. Photodermatol Photoimmunol Photomed 2008; 24: 322-9.
10. Li L, Fukunaga-Kalabis M, Yu H, et al. Human dermal stem cells differentiate into functional epidermal melanocytes. J Cell Sci 2010; 123: 853-60.